INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 9 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $220,658 | +22.6% | 225,000 | 0.0% | 0.04% | +20.0% |
| Q2 2023 | $179,910 | -3.8% | 225,000 | 0.0% | 0.03% | -16.7% |
| Q1 2023 | $187,043 | +9.8% | 225,000 | 0.0% | 0.04% | 0.0% |
| Q4 2022 | $170,303 | +0.2% | 225,000 | 0.0% | 0.04% | +63.6% |
| Q3 2022 | $170,000 | +18.1% | 225,000 | 0.0% | 0.02% | +15.8% |
| Q2 2022 | $144,000 | +4.3% | 225,000 | 0.0% | 0.02% | +5.6% |
| Q1 2022 | $138,000 | +1.5% | 225,000 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $136,000 | 0.0% | 225,000 | 0.0% | 0.02% | +12.5% |
| Q3 2021 | $136,000 | -11.7% | 225,000 | 0.0% | 0.02% | -11.1% |
| Q2 2021 | $154,000 | +6.2% | 225,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $145,000 | +5.8% | 225,000 | 0.0% | 0.02% | -14.3% |
| Q4 2020 | $137,000 | -43.6% | 225,000 | -35.7% | 0.02% | -52.3% |
| Q3 2020 | $243,000 | -3.6% | 350,000 | 0.0% | 0.04% | -22.8% |
| Q2 2020 | $252,000 | -17.1% | 350,000 | 0.0% | 0.06% | +23.9% |
| Q1 2020 | $304,000 | -34.6% | 350,000 | 0.0% | 0.05% | -14.8% |
| Q4 2019 | $465,000 | +46.2% | 350,000 | 0.0% | 0.05% | +50.0% |
| Q3 2019 | $318,000 | +6.0% | 350,000 | +16.7% | 0.04% | +12.5% |
| Q2 2019 | $300,000 | – | 300,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 55,943,000 | $34,742,000 | 1.33% |
| PenderFund Capital Management Ltd. | 5,000,000 | $3,839,000 | 0.98% |
| Context Capital Management, LLC | 7,485,000 | $4,494,000 | 0.62% |
| Opti Capital Management, LP | 7,000,000 | $4,250,000 | 0.47% |
| Soros Fund Management | 32,298,000 | $19,611,000 | 0.37% |
| Shaolin Capital Management LLC | 7,000,000 | $4,175,000 | 0.29% |
| Weiss Asset Management LP | 3,500,000 | $2,084,000 | 0.09% |
| CSS LLC/IL | 2,825,000 | $1,681,000 | 0.06% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 225,000 | $137,000 | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 25,000,000 | $15,009,000 | 0.02% |